FindTrial
Sign In

A Study on the Effect of Singing Bowl Music Therapy on the Quality of Life of Patients with Non-Small Cell Lung Cancer in Palliative Care

A Study on the Effect of Singing Bowl Music Therapy on the Quality of Life of Patients with Non-Small Cell Lung Cancer in Palliative Care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000315
Enrollment
Unknown
Registered
2026-02-09
Start date
2025-12-20
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Experimental group:The experimental group received a 12-week Tibetan Singing Bowl (TSB) sound therapy intervention on the basis of palliative care and standard care, including five on-site TSB interve
control group:The control group received palliative care and standard care.

Sponsors

Tangdu Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria Meet the diagnostic criteria for non-small cell lung cancer in ICD-11, with tumor stage between II-IV; Undergoing palliative treatment (chemotherapy, radiotherapy, targeted therapy, immunotherapy); Aged = 18 years, regardless of gender; 4) Voluntarily participate in this clinical trial and sign a written informed consent form; Able to communicate online using social platforms; Expected survival period = 6 months; Karnofsky Performance Status score = 50. (7) Voluntarily participate in the study, sign the informed consent form, have good compliance, and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (1) Central nervous system metastasis with cognitive dysfunction; (2) Those with severe abnormalities in cardiopulmonary function; (3) Having a history of mental illness and taking psychiatric drugs; (4) Unable to understand the assessment scales and experimental intervention guidelines; (5) Severe hearing impairment. Removal Criteria: (6) Requesting to withdraw from the experiment during the research process; (7) No longer meeting the inclusion criteria due to disease progression; Dropout during the research process.

Design outcomes

Primary

MeasureTime frame
Quality of life;Anxious and depressive emotions;—

Secondary

MeasureTime frame
Sleep quality;Psychological pain;Pain;blood pressure;Heart rate;Respiratory rate;Peripheral blood oxygen saturation;Pupillary distance;—

Countries

China

Contacts

Public ContactZheng Dongxu

Department of Traditional Chinese Medicine, Tangdu Hospital, Air Force Medical University

zhengdongxu16@163.com13679163951

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026